Summary Biodesix Inc (Biodesix) is a molecular diagnostics company which discovers, develops and commercializes multivariate protein and genomic diagnostic blood tests in oncology for patients and doctors to enable precision medicine.These tests are used for early detection of diseases, diagnosis accuracy, disease monitoring and also provide improved therapeutic guidance for cancer patients.
Biodesix’s product portfolio includes GeneStrat, a gene panel of clinically actionable mutations for tumor profiling for patients with advanced lung cancer; and VeriStrat, a serum proteomic test for patients with non-small cell lung cancer.The company collaborates with leading researchers to develop companion diagnostics for use with therapeutic agents and work in partnership with biotechnology and pharmaceutical companies such as Aveo Oncology and Biognosys.
Biodesix is headquartered in Boulder, Colorado, the US.
Biodesix Inc - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
350 pages •
By Global Industry Analysts
• Oct 2019
In situ Hybridization market worldwide is projected to grow by US$279.8 Million, driven by a compounded growth of 5.6%. Fluorescence In Situ Hybridization (FISH), one of the segments analyzed and sized in this study, displays the potential to grow at over 5.9%. The shifting dynamics supporting this growth makes it critical for businesses in...
The global immunoassay market is expected to reach US$ 37,987.8 Mn in 2027 from US$ 21,800.0 in 2018. The market is estimated to grow with a CAGR of 6.5% from 2019-2027. The market for immunoassay is expected to grow, owing to factors such as rising incidences of chronic and infectious diseases, technological advancements in immunoassay...
Infectious Disease Testing Instrumentation: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics--Latest Microbiology Analyzers and Strategic Profiles of Leading Suppliers, 2019 This 86-page report reviews major analyzers used for microbiology...
Global Nucleic Acid Testing/NAT Market, 2019-2023: Supplier Shares by Country, Emerging Technologies and Strategic Profiles of Leading Suppliers This 180-page report provides detailed analyses of current and emerging molecular diagnostic technologies, and their potential market applications, including DNA sequencing,...
Molecular Diagnostics Market, 2019-2023: Supplier Shares by Product and Country, Emerging Technologies, Strategic Profiles of Leading Suppliers This 185-page report provides detailed analyses of current and emerging molecular diagnostic technologies, and their potential market applications, including DNA sequencing,...
Latin America Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: A 7-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation and Opportunities This new 7-country report is available by country, market segment, section, or individual...
Blood Glucose Meters - Medical Devices Pipeline Assessment, 2019 Summary Medical Devices sector report, "Blood Glucose Meters - Medical Devices Pipeline Assessment, 2019", provides an overview of Blood Glucose Meters currently in pipeline stage. The report provides comprehensive information...
The healthcare-associated infectious disease diagnostics market is expected to grow at a CAGR of over 8% during the period 2018–2024. The growing demand for POC tests for the diagnosis of HAIs will have a positive impact on the growth of the global healthcare-associated infectious disease diagnostics market during the forecast period....
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.